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Background: Carriers of balanced translocations are at high risk for unbalanced gametes which can result in
recurrent miscarriages or birth defects. Preimplantation genetic diagnosis (PGD) is often offered to select balanced
embryos. This selection is currently mainly performed by array CGH on blastomeres. Current methodology does not
take into account the phase of the cell cycle, despite the variable copy number status of different genomic regions
in S phase.
Results: Cell lines derived from 3 patients with different chromosomal imbalances were used to evaluate the
accuracy of single cell array CGH. The different cell cycle phases were sorted by flow cytometry and 10 single cells
were picked per cell line per cell cycle phase, whole genome amplified and analyzed by BAC arrays, the most
commonly used platform for PGD purposes. In contrast to G phase, where the imbalances were efficiently
identified, less than half of the probes in the regions of interest indicated the presence of the aberration in 17
S-phase cells, resulting in reduced accuracy.
Conclusions: The results demonstrate that the accuracy to detect segmental chromosomal imbalances is reduced
in S-phase cells, which could be a source of misdiagnosis in PGD. Hence, the cell cycle phase of the analyzed cell is
of great importance and should be taken into account during the analysis. This knowledge may guide future
technological improvements.Background
Up to 15% of the couples confront fertility problems and
1% of the couples attempting to conceive a child experi-
ence recurrent miscarriage (RM), defined as the loss of
at least three consecutive pregnancies [1]. In approxi-
mately 3-6% of couples with RM the cause is a balanced
chromosomal rearrangement carried by one of the part-
ners [2,3], which may result in segmental aneuploid con-
ceptions incompatible with life [4]. In order to avoid
miscarriages or the possibility of an affected child, pre-
implantation genetic diagnosis (PGD) can be offered to se-
lect those embryos which are chromosomally balanced.
PGD requires the use of assisted reproduction technology
(ART) and it has already been used since the beginning of
the ‘90s, initially applied for monogenic diseases [5] and
shortly after for chromosomal rearrangements [6]. At the
same time, preimplantation genetic screening (PGS) to* Correspondence: joris.vermeesch@uzleuven.be
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article, unless otherwise stated.identify numerical chromosome aberrations was applied
to embryos from women of advanced age (advanced ma-
ternal age, AMA) and those who had suffered repeated
implantation failure (RIF) and RM [7,8].
Overall, during the 10 years of data collection by the
European Society of Human Reproduction and Embryology
(ESHRE), there have been 27,630 cycles to oocyte retrieval
(OR) reported, that resulted in 202,357 fertilized oocytes
and the transfer of 35,944 embryo. For 16% of these cycles
the indication was chromosomal abnormalities [9].
Initially, fluorescence in situ hybridization (FISH) was
used for chromosome analysis, but technical difficulties
and restrictions associated to this method lately lead to
the introduction of array based comparative genomic
hybridization (aCGH), which allows the simultaneous
analysis of all 24 chromosomes at once, and thought to
be a more robust and reliable test. The ESHRE PGS task
force has completed pilots regarding the use of aCGH
for PGD purposes [10,11], and a multi-center random-
ized controlled trial has been set up. Bacterial artificial
chromosome (BAC) aCGH-based PGD is currently byntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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the gold standard. As it offers a resolution down to 2.5
Mb in single cells, the majority of translocations can be
analyzed and even for translocations with smaller ex-
changed fragments, provided that three out of the four
fragments of interest are above the resolution limit, the
unbalanced products can be detected [12-14].
SNP arrays [15-19] and even single-cell sequencing [20-23]
seem to be promising, but they are still being developed
and need to be further optimized and validated, while is-
sues regarding the ethical concerns related to the large
amount of genetic information that will be available from
each embryo still need to be addressed.
Although the literature abounds in studies evaluating
different PGD approaches, none of the current methods
take into consideration the cell cycle phase of the cells
used for the analysis. It is known that the DNA of the
S-phase cell is progressively replicated from multiple ori-
gins of replication (ORIs) [24] and log2 ratios of single
S-phase cells follow the patterns of early and late replica-
tion domains [25]. Different replicons are organized in
replication domains that follow similar replication timing,
forming early and late replication domains [26]. But the
firing of the different ORIs occurs stochastically. Hence,
at a given time point the genetic copy number (CN)
profiling of an S-phase cell will demonstrate different loci
with CN status of 2, 3 or 4, depending on the replication
status of this specific locus. It has also been proposed
that the DNA replication process could result in er-
rors of interpretation (misdiagnosis) in proliferating cells
by FISH [27].
It still remains unanswered, though, to what extent this
oscillation can influence the accuracy of CN profiling in
single cells and to what extent the sensitivity and the spe-
cificity of CN determination would be affected. On one
hand, the increased number of false positive calls could
lead to misdiagnosis if they are falsely interpreted as real
genuine structural aberrations. On top of that, some aber-
rations could be masked due to the high S-phase genome
fluctuation and missed when S-phase cells are analyzed by
aCGH, thus leading to false negative calls and misdiag-
nosis. To address these questions and evaluate the effect
of the cell cycle phase on the detection of chromosomal
aberration, cell lines with known imbalances were grown
in log phase and flow sorted to select S- and G0/G1-phase
cells and the copy number profiles of individual cells were
analyzed by aCGH.
Results
In order to study the effect of the cell cycle phase on the
specificity and sensitivity of copy number aberration de-
tection we used cell lines with known chromosomal im-
balances. Two EBV cell lines with a 25.16 Mb interstitial
duplication of 7p and an unbalanced translocation, witha 24 Mb duplication of 9p and an 8 Mb deletion of 18p,
respectively, as well as one fibroblast cell line with a 9.3
Mb duplication of 18p and a 1.7 Mb deletion of 20p, due
to an unbalanced translocation were selected to cover a
range of different aberrations of various sizes. After sort-
ing of the different cell cycle phases by flow cytometry,
the genomic content of populations of cells, as an internal
control for the sorting procedure, as well as individual
S- and G0/G1-phase cells were analyzed by aCGH using
24Sure + BAC arrays, the most commonly used arrays for
PGD purposes. An imbalance was regarded to be reliably
detected in its full length when the value of log2 intensity
ratio passed the threshold of +0.3 for gains or −0.3 for
losses for at least half of the probes in the region of inter-
est with a minimum of 10 consecutive probes meeting this
criterion.
Populations of S-phase cells result in more scattered
aCGH profiles compared to G0/G1-phase cell populations
To compare the aCGH profiles of S- and G0/G1-phase
cells and as an internal control for the successful separ-
ation of the corresponding subpopulations by FACS, we
hybridized genomic DNA extracted from many cells of
S- and G0/G1-phase populations against control DNA of
the opposite sex using BAC arrays. As depicted in Figure 1,
the aCGH profiles produced by the two distinct subpopu-
lations of cells differ considerably. In the plots deriving
from the G0/G1 subpopulation, we can clearly see the
smooth profile expected by genomic samples. On the con-
trary, S-phase subpopulations result in a more oscillating
profile characterized by remarkably deviating log2 inten-
sity ratios throughout the genome.
The replication profile of the sorted S- and G0/G1-phase
cells matches the expected profile according to known
replication domains
To confirm the cell cycle phase identity of the isolated
cells, we analyzed the log2 values of the cells in light of
the known replication domains for the cell type, as de-
scribed in our previous study [25]. In short, we detected
an oscillation in the log2 ratios across the genome of the
S-phase cells, in line with the known replication timing.
In S-phase cells, regions replicating early in S-phase dem-
onstrate high log2 ratios and late replicating regions dem-
onstrate low log2 ratios, while in G0/G1-phase cells this
wave is absent (average G0/G1 = 0,13; average S = 0,27;
Mann Whitney: p < 0,0001) (See Additional file 1). The
log2 intensity ratios of the S-phase cells also showed a
significantly higher correlation to the cell type- and locus-
matching replication factor values obtained from multi-
cell DNA studies [28,29] when compared to G0/G1-phase
cells.
For 33 out of the 35 single EBV cells and for 11 out of
the 13 fibroblasts, the cell cycle phase attributed by the
Figure 1 aCGH using DNA isolated from S- and G0/G1- populations of three cell lines. aCGH plots of genomic samples with chromosomes
on the X-axis and fluorescence intensity log2 ratios on the Y-axis deriving from S- (left) and G0/G1-phase (right) sorted subpopulations of multiple
cells for the three tested cell lines. (A) dup(7)(p14.3p21.3), (B) der(18)t(9;18)(p21.3;p11.3) and (C) der(20)t(18;20)(p11.22;p13).
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across the genome according to the replication timing
confirmed the cell cycle phase of the flow sorted fraction
(See Additional file 1). The cells not matching these cri-
teria for S- or G0/G1-phase cells could be attributed to
either an inaccuracy in the FACS experiment, natural
progression of the cell in between the FACS and the cell
lysis, or substandard amplification or hybridization lead-
ing to the underlying patterns.
S phase interferes with the detection of chromosomal
aberrations
To assess the sensitivity of the detection of copy number al-
terations in S- and G0/G1-phase cells we evaluated the fre-
quency of calling of the known aberrations. We hybridizedWG amplified single-cell S- and G0/G1-phase samples
against control WG amplified DNA of the opposite sex,
using BAC arrays. Representative examples of the analysis
of the aCGH data are shown on Figure 2, while all the
results for the chromosomes of interest are shown on
Additional files 2, 3, 4, 5, 6 and 7. To more specifically es-
timate the impact of false positive calls in S-phase cells in
the regions of interest, we counted the number of the
BAC probes that detected an imbalance within these re-
gions in the cell lines where there are no such aberra-
tions. The results are summarized in Additional file 8.
In short, the number of probes passing the threshold of
0.3 is quite low and in most cases remains beneath 50% of
the probes in the region of interest, a number that would
not have been efficient for the detection of an imbalance.
Figure 2 aCGH using whole genome amplified DNA from single S- and G0/G1-phase cells of three cell lines. aCGH plots of single cell
samples with chromosomes on the X-axis and fluorescence intensity log2 ratios on the Y-axis. Representative S- (left) and G0/G1-phase (right)
sorted cells for the three tested cell lines, (A) dup(7)(p14.3p21.3), (B) der(18)t(9;18)(p21.3;p11.3) and (C) der(20)t(18;20)(p11.22;p13), are shown.
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probes passing the threshold are within the same range as
the S phase cells of the cell line carrying the aberration of
interest. More specifically, in 4/16 S-phase cells from the
cell lines used as controls, 8 to10 probes (out of the 40
probes in the region of interest) are passing the threshold,
indicating the presence of a duplication on 7p.Cell line 46,XX,dup(7)(p14.3p21.3)
There are 40 BAC clones covering the 25.16 M duplicated
region on 24Sure + arrays (RP11-172O13 – RP5-1143H19).
Seven G0/G1- and 10 S-phase cells were selected for ana-
lysis based on the WGA and aCGH quality. In 1 G-phase
sample, cell G0/G1_1_3, less than half of the probes indi-
cated a log2 intensity ratio of a duplication, where the distal
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vated log2 intensity ratio of only two probes. However, in
contrast to G-phase cells, there were several detection in-
accuracies in the 10 S-phase cells that were analyzed
(Table 1). Only in 2 of them (S_1_1 and S_1_10) the dupli-
cation was accurately called due to the elevated log2 in-
tensity ratios of more than half of the BAC clones. In the
remaining 8 samples, the calling threshold was passed by
less than half of the probes in the region of interest, and
notably in 6 (S_1_2, S_1_3, S_1_5, S_1_6, S_1_8 and
S_1_9) more than 2/3 of the probes failed to do so, leading
to underestimation or even failed detection (S_1_9) of the
duplication. Additionally, in 5 of these samples (S_1_2,
S_1_3, S_1_5, S_1_8 and S_1_9), the intensity log2 ratios
for more than 10 consecutive probes did not pass the
threshold for the detection of the duplication at one side











S_1_1 25 S_2_1 26
S_1_2 11 S_2_2 21
S_1_3 13 S_2_3 19
S_1_4 18 S_2_4 29
S_1_5 8a S_2_5 22
S_1_6 9a S_2_6 25
S_1_7 18 S_2_7 28
S_1_8 13 S_2_8 27
S_1_9 10a S_2_9 18
S_1_10 27 S_2_10 31
G0/G1_1_1 23 G0/G1_2_1 16
G0/G1_1_2 20 G0/G1_2_2 19
G0/G1_1_3 18 G0/G1_2_3 25
G0/G1_1_4 28 G0/G1_2_4 36
G0/G1_1_5 24 G0/G1_2_5 31
G0/G1_1_6 20 G0/G1_2_6 23
G0/G1_1_7 25 G0/G1_2_7 22
G0/G1_2_8 31
B
Underestimationb No calla Total number of false n
S 14 3 17
G0/G1 3 1 4
(A) Number of probes indicating the presence of an imbalance in the regions of int
phase and cell line. In brackets the number of probes in the regions of interest. The
significantly higher in G0/G1- compared to S-phase cells (Mann Whitney p = 0.029).
detection rate is significantly higher in G0/G1- compared to S-phase cells (Chi-squa
aThe imbalance was not automatically indicated by the software.
bThe proximal or distal end of the imbalance was very weakly detected or not dete
cThe log2 intensity ratios for 1 cell were indicative of a deletion in the control sampCell line 46,XX,der(18)t(9;18)(p21.3;p11.3)
There are 42 and 28 BAC clones covering the 24 Mb du-
plication on 9p (RP11-143M1 – RP11-149I2) and 8 Mb
deletion on 18p (RP11-683L23 – RP11-162D20), respect-
ively. From the 8 G0/G1-phase cells that were analyzed,
the imbalances were indicated by the altered log2 intensity
ratios of more than half of the probes in 6. For cell G0/
G1_2_2, the 9p duplication was marginally detected by
19/42 probes, while in the case of cell G0/G1_2_1, which
was also highlighted by the replication domain analysis as
deviating from the normal profile of G-phase cells, both
imbalances were poorly called. On the contrary, there
were 4 out of the 10 S-phase cells of this cell line, where
the presence of one of the imbalances was indicated by al-
tered log2 intensity for less than half of the probes
(Table 1). More specifically, the 9p duplication was under-










3a S_3_1 7 7
13 S_3_2 14 7
21 S_3_3 4a 6
20 S_3_4 16 7
25 S_3_5 11 6





13 G0/G1_3_1 2a 7
17 G0/G1_3_2 17 6
19 G0/G1_3_3 15 7
23 G0/G1_3_4 19 5
17 G0/G1_3_5 17 6
20 G0/G1_3_6 17 7
20 G0/G1_3_7 23 4
19
egative Total number of false positive Total number of cells
5c 26
0 22
erest according to the BAC array log2 intensity ratios of single cells per cell
number of probes indicating the presence of the imbalance of interest was
(B) Total number of miss-calls per cell cycle phase. The accurate imbalance
re test p = 0.001).
cted at all.
le, while there is a duplication in the same region in the cell line of interest.
Dimitriadou et al. Molecular Cytogenetics 2014, 7:46 Page 6 of 10
http://www.molecularcytogenetics.org/content/7/1/46end of the duplication was very weakly detected or not de-
tected at all, respectively. The deletion of 18p was under-
estimated in S_2_2 and not detected at all in S_2_1, where
the diminished log2 intensity ratios for only 3 probes in
the region of interest were indicative of the deletion.
Cell line 46,XY,der(20)t(18;20)(p11.22;p13)
This cell line carries smaller imbalances. There are 30
BAC probes covering the 9.3 Mb 18p duplication (RP11-
683L23 – RP11-36J15) and only 8 cover the 1.7 Mb 20p
deletion (RP11-530N10 – RP11-77C3). Despite the size
of this deletion, it was possible to discern the presence
of the imbalance in both S- and G-phase cells. The log2
intensity ratio threshold for the detection of the 18p du-
plication was passed for more than half of the probes in
6 out of 7 G-phase cells that were analyzed, with the
exception of cell G0/G1_3_1 which was also previously
detected as deviating from typical G-phase cell profiles
through the replication domain analysis. In contrast to
that, the log2 intensity ratios of less than half of the
probes covering the duplicated region passed the thresh-
old for the detection of the duplication in 5 (S_3_1,
S_3_2, S_3_3, S_3_5 and S_3_6) of the 6 S-phase cells
that were analyzed (Table 1). The effect was even more
profound for 2 of those cells (S_3_1 and S_3_3), where
less than 1/3 of the intensity ratios of less than 1/3 of
the probes were above the detection threshold, fact that
could even lead to no detection of the imbalance in the
case of cell S_3_3.
The analysis of all S- and G0/G1-phase cells showed
no statistically significant difference in the number of
probes passing the log2 ratio threshold indicating the
presence of the imbalance of interest between the two
groups (Mann Whitney p = 0.371). The analysis of the
larger imbalances though (>9 Mb), that can also be more
accurately detected by the 24Sure + array, showed a sta-
tistically significant correlation of the number of the
probes indicative of the presence of the imbalance of
interest and the cell cycle phase of the cell, with less
probes passing the log2 ratio threshold of 0.30 in S- com-
pared to G0/G1-phase cells (See Table 1A, Mann Whitney
p = 0.029). Moreover the accurate imbalance detec-
tion rate is significantly higher in G0/G1- compared to
S-phase cells (See Table 1B, Chi-square test p = 0.001),
leading in higher false negative rates in S phase.
Discussion
PGD is offered to couples that carry balanced transloca-
tions and wish to have healthy children. aCGH is becom-
ing the standard approach for the detection of structural
DNA imbalances has turned aCGH into the gold standard
in the field. Current methodology does not take into ac-
count the cell cycle phase of the analyzed cell. Here we
demonstrate that the results acquired after the analysis ofS-phase cells differ from those of G-phase cells and
we show that the accuracy of single cell copy number
profiling is cell cycle dependent. In conformity with our
previous work, we report increased false positive CNV de-
tection genome-wide in S-phase cells (Figure 2). The vari-
ability in DNA-replication status for consecutive loci
across the genome of S-phase cells can not only lead to
false positive, but more importantly also to false negatives
for structural DNA imbalances. In contrast to G-phase
cells, where the imbalances were efficiently detected, we
revealed that 17 out of the 26 S-phase cells where less
than half of the probes in the regions of interest indicated
the presence of the aberration, leading to underestimation
of the size of the imbalance, or even no detection of at
least one of the imbalances in 3/26 S-phase cells. Here
we show that in S-phase cells CNV calling by aCGH is
less sensitive.
A total of 3 misdiagnoses for chromosomal rearrange-
ments have been reported after 2731 embryo transfers,
giving a low misdiagnosis rate of 0.1% [30]. High-quality
array profiles are required to study the integrity of single
cell genomes with maximum possible sensitivity and
specificity. The concept of the cell cycle dependent ac-
curacy has already been mentioned by Pujol et al. [27].
They reported that the use of cells in S phase for PGD by
FISH could lead to misdiagnosis in 7% of the cells due to
presence of double dots in replicating chromatin domains
and misinterpretation of the result [27]. More recently, it
was also reported that the analysis of array data from fast
dividing cells can be challenging due to oscillating array-
CGH patterns. These patterns could be explained by
the presence of a high proportion of replicating cells in
S phase, especially if a specific clone prevails [31]. We pre-
viously demonstrated that the analysis of single cell ge-
nomes by array CGH is indeed challenging and can be
affected by the cycle stage of the cell [25].
Even when performing stringent quality controls at
each step of the aCGH-based PGD procedure, from bi-
opsy, DNA amplification and quality, labeling efficiency,
hybridization performance, image scanning, and data ex-
traction and analysis, the analysis of S-phase cells could
lead to unsatisfactory and low quality data. The analysis
of such data can result in false-positive detection of CN
alterations or masking the identification of existent CN
imbalances. False positive CN calls could easier occur
leading to the rejection of a normal embryo for transfer.
False negative CN calls, on the other hand, can be even
more dangerous, as they could lead to misdiagnosis in
case an abnormal embryo is transferred. Fortunately, the
detection of an unbalanced embryo is usually based on
the detection of more than one segments [12]. Neverthe-
less, the detection of imbalances, especially of gains and
smaller losses, as single events could be more challen-
ging. Here we show that duplications varying from 9 to
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cells. Consequently, it would be recommendable to use
G0/G1-phase blastomeres for PGD purposes.
In search for a solution for the false negative calls we
tried to bioinformatically correct for them (data not shown).
The correction against the recurrent fluctuation that cor-
responds to specific replicating domains in S phase would
hopefully lead to more clear copy number profiles and
would finally unmask the aberrations of interest. Unfortu-
nately, this was not the case. We did not manage to im-
prove the detection sensitivity and specificity after the
computational correction algorithm [32] that we applied.
It is possible that new algorithms more powerful and suit-
able for these purposes could be developed in the future.
One could argue that increasing the number of probes in
the region of interest could consequently increase the spe-
cificity and sensitivity of the aneuploidy calling. Taking
into account that the typical fluctuation observed in
aCGH profiles of S-phase cells is not due to technical as-
pects, but the result of an innate characteristic of the
DNA of cells in S phase, we would not expect the increase
in the number of probes to overcome the problem. A pos-
sible solution could be the selection of cells which are not
in S phase. One approach might be the use of a cell cycle
phase-specific marker indicating the cell stage in which
the nucleus analyzed is found [27]. Another approach may
be the use of live imaging systems for monitoring the mor-
phokinetics of the embryo development, which will enable
us to follow the embryo development in real time [33].
Embryo biopsy could then be performed immediately after
a cell division event, ensuring this way that the cell to be
analyzed will be in the G phase of its cell cycle. Finally,
the use of blastocyst stage biopsy could possibly lead
to less S-phase-biased results. Given that the DNA of
more than one cells is analyzed and the possibility that
the 5–10 biopsied trophectoderm cells are in different cell
cycle phases, we could expect improved, less fluctuat-
ing profiles.
Although the discussion regarding the use of SNP arrays
and more recently single cell massive parallel sequencing
(MPS) for PGD purposes has been going on for some time
now, their application is still in primary stage and aCGH
remains the gold standard. Nevertheless, for the future
implementation of these techniques in the clinic, it should
be kept in mind that the same problems regarding the
analysis of S-phase cells will be faced.
Conclusions
Our results demonstrate that the accuracy of segmental
chromosomal imbalances detection by aCGH is cell-cycle
dependent and, more specifically, reduced in S-phase sin-
gle cells. In S phase, logR intensity ratios are remarkably
variable and at the same time the frequency of false nega-
tive calls are increased in aCGH plots. Consequently, thisquality compromise observed in aCGH data from S-phase
cells could be a source of misdiagnosis in PGD. Hence,
the cell cycle phase of the analyzed cell is of great im-
portance and should be taken into account during the
analysis. This knowledge may guide future technological
improvements.
Methods
Cell lines and cell culture
Established Epstein-Barr virus (EBV) immortalized lympho-
blastoid cells and immortalized fibroblasts were grown in
75-cm2 plastic flasks (BD Falcon, USA) under standard
culture conditions in Dulbecco's Modified Eagle Medium/
Nutrient Mixture F-12 (DMEM/F12) (Gibco, USA) medium
complemented with 10% Fetal Bovine Serum (FBS) (Thermo
Scientific, USA). All cell lines carried known structural
chromosomal aberrations. More specifically, two EBV cell
lines with a duplication and an unbalanced translocation,
respectively, and one fibroblast cell line with an unbal-
anced translocation were used. The first cell line was de-
rived from a female 46,XX,dup(7)(p14.3p21.3) carrier of a
25.16 Mb duplication, the second had a karyotype 46,XX,
der(18)t(9;18)(p21.3;p11.3) leading to a 24 Mb duplication
on the short arm of chromosome 9 and an 8 Mb deletion
on the short arm of chromosome 18 and the third one
was a 46,XY,der(20)t(18;20)(p11.22;p13) cell line with a
9.3 Mb duplication on the short arm of chromosome 18
and a smaller deletion of 1.7 Mb on the short arm of
chromosome 20.
Cell staining and Fluorescent activated flow cytometry
Live cells were stained with Vybrant DyeCycle Orange
stain (Invitrogen, USA) according to the manufacturer’s
protocol. In short, cells were washed and diluted to a final
concentration of 106 cells/ml in 1xPBS (Gibco/Invitrogen,
USA) and consequently stained with 2 μl/106 cells Vybrant
DyeCycle Orange at 37°C for 30 min. Fluorescence-
activated cell sorting (FACS) of all 3 cell lines for the dis-
tinction and collection of the three different cell cycle
phases followed, using FACSAria III with FACSDiva soft-
ware (BD Biosciences, CA). The sorting parameters were
strict (single cell selection only, low collection rate) and
the window of selection as narrow as possible, to ensure
the highest possible purity of the isolated subpopulation
(See Additional file 9).
Isolation of cell subpopulations and individual cells and
whole genome amplification
Cell subpopulations in S- and G0/G1-phase were col-
lected from cultured cell populations after FACS. Sorted
cells were individually picked using a mouth pipetting
system as described [34]. Single cells were separately col-
lected per cell phase per cell line and single cell whole
genome amplification (WGA) was performed using the
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ing to manufacturer’s protocol. WGA products were puri-
fied using the High Pure PCR Product Purification Kit
(Roche, DE).
Fractions of 1-2×106 of S- and G0/G1-phase cells were
also collected, lyzed by overnight incubation at 50°C
in lysis buffer (0.25 mM EDTA, 0.5% SDS and 0.1 mg/ml
proteinase K in 1×PBS), and DNA was extracted using
standard phenol/chloroform extraction and ethanol
precipitation.
Several steps of quality assessment of the samples were
applied. First the quality and quantity of the WG amplified
DNA was assessed. The concentration as well as the quality
of amplified and genomic DNA was evaluated by nanodrop
spectophotometer (ND-1000, Nanodrop Technologies,
USA). Only the single cells that gave an amplification prod-
uct of 2 μg or more were further used for hybridization on
an array. No amplification (n = 1) or low yield (n = 5) of
WG amplified DNA could be attributed to the non-transfer
of a cell in the tube or to transfer of cellular fragments in-
stead of good quality intact cells. Samples with bad 260/280
and 260/230 ratios (n = 2) were also not further used.
BAC array hybridization and analysis
Array CGH for both genomic and single cell whole genome
amplified samples was carried out using 24sure + V1.0
BAC Cytochip microarrays, the most commonly used ar-
rays in PGD for the detection of unbalanced translocations
and subchromosome imbalances, as they are enriched with
more probes covering the pericentromeric and subtelo-
meric regions. Four different batches of 24sure + V1.0 BAC
arrays (BlueGnome, UK) were used following the standard
protocol (BlueGnome 24sure protocol, www.cytochip.com).
For the hybridizations, 200 ng of sample DNA and equal
amount of commercially available reference DNA of the
opposite sex (sex mismatch experiments) were labeled for 2
h by random primer labeling (BlueGnome, UK) using Cy5-
and Cy3-dCTPs, respectively. For multi-cell samples, com-
mercially available reference male or female DNA (Krea-
tech, NL) was used, while for the hybridizations with
single-cell amplified material, SureRef male or female refer-
ence DNA (BlueGnome, UK). Hybridization and washing
was performed according to the manufacturer’s protocol.
Scanning was performed using a DNA-microarray scan-
ner (Agilent Technologies, UK), the separation of the du-
plex raw images by ImageViewer and the analysis of the
data by BlueFuse v3.0 software (BlueGnome, UK). The
evaluation of the array data and threshold settings to call
an abnormality were performed according to the guide-
lines of the manufacturer and samples that failed to pass
these criteria (n = 4) were not used for further analysis.
Gains and losses were called when the log2 ratio of BAC
clones of interest were above or below the threshold of
0.3, respectively.Data normalization and copy number calling
For further analysis, the raw data were feature extracted
using GenePix Pro 6.0 software (Axon, Molecular Devices).
The data were normalized such that the ratio of the means
for all features would equal to 1. The raw grp files pro-
duced after normalization and feature extraction were used
as input for R scripts (R version 2.13.2 – www.r-project.
org) using different packages [35-37]. Log2 intensity ratios
with a signal to noise less than 2 were excluded from the
array. Subsequently, the data was preprocessed by the
‘Channel clone’ method described in Cheng et al. [32], seg-
mented by GLAD algorithm and called by the CGHcall
package in R [38,39].
Comparison of log2 intensity ratios to predicted
replication domains
For the analysis of cell cycle phase identity, the method-
ology as described in Van der Aa et al. [25] was used.
Log2 values of fibroblast cells were compared to replica-
tion ratio data of IMR90 fetal lung fibroblasts (369858–3)
[28] and log2 ratios of EBV cells were compared to repli-
cation ratios of C0202 lymphoblastoid cells (replicate 1,
GEO accession number GSE20027) [29].Additional files
Additional file 1: Replication profiles of the single S- and G0/G1-
phase cells according to known replication domains. (A) Plots for
EBV-transformed lymphocytes and (B) corresponding plots for fibroblasts.
On the left: The X-axis depicts the % GC content per probe, the Y-axis
the log2 intensity ratios per sample. Each line is a Loess fit using the data
of a single-cell sample, with S-phase cells shown in blue (mean in red)
and G0/G1-phase cells in black (mean in green). On the right: Boxplots
for single cells depicting autosomal log2 intensity ratios that were pooled
per cell cycle phase and per early or late DNA-replication domain. Boxplots
show the median of the log2 intensity ratios (central line) and the quartiles
(box and whiskers).
Additional file 2: aCGH profiles of the derivative chromosomes for
all the single cells analyzed. aCGH plots of the chromosomes of interest
with fluorescence intensity log2 ratios on the X-axis and chromosomal
position on the Y-axis. Plots for all single-cell samples are depicted:
(A) dup(7)(p14.3p21.3) G0/G1-phase cells.
Additional file 3: aCGH profiles of the derivative chromosomes for
all the single cells analyzed. aCGH plots of the chromosomes of interest
with fluorescence intensity log2 ratios on the X-axis and chromosomal
position on the Y-axis. Plots for all single-cell samples are depicted:
(B) dup(7)(p14.3p21.3) S-phase cells.
Additional file 4: aCGH profiles of the derivative chromosomes for
all the single cells analyzed. aCGH plots of the chromosomes of interest
with fluorescence intensity log2 ratios on the X-axis and chromosomal
position on the Y-axis. Plots for all single-cell samples are depicted:
(C) der(18)t(9;18)(p21.3;p11.3) G0/G1-phase cells.
Additional file 5: aCGH profiles of the derivative chromosomes for
all the single cells analyzed. aCGH plots of the chromosomes of interest
with fluorescence intensity log2 ratios on the X-axis and chromosomal
position on the Y-axis. Plots for all single-cell samples are depicted:
(D) der(18)t(9;18)(p21.3;p11.3) S-phase cells.
Additional file 6: aCGH profiles of the derivative chromosomes for
all the single cells analyzed. aCGH plots of the chromosomes of interest
with fluorescence intensity log2 ratios on the X-axis and chromosomal
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http://www.molecularcytogenetics.org/content/7/1/46position on the Y-axis. Plots for all single-cell samples are depicted:
(E) der(20)t(18;20)(p11.22;p13) G0/G1-phase cells.
Additional file 7: aCGH profiles of the derivative chromosomes for
all the single cells analyzed. aCGH plots of the chromosomes of interest
with fluorescence intensity log2 ratios on the X-axis and chromosomal
position on the Y-axis. Plots for all single-cell samples are depicted:
(F) der(20)t(18;20)(p11.22;p13) S-phase cells.
Additional file 8: Estimation of false positive detection rate of the
derivative chromosomes in control single S- and G0/G1-phase cells
of three cell lines. Number of probes falsely indicating the presence of
an imbalance in the regions of interest according to the BAC array log2
intensity ratios in S-phase single cells of cell lines not carrying an aberration
involving this region. In brackets the number of probes in the regions of
interest. *The log2 intensity ratios were indicative of a deletion in the
control sample, while there is a duplication in the same region in the cell
line of interest.
Additional file 9: Cell sorting procedure. Representative plot illustrating
the cell sorting procedure by FACS with relative DNA content on the X-axis
and the cell count on the Y-axis. The marked windows correspond to the
fractions which were collected for each cell subpopulation (G0/G1-, S- and
G2/M-phase).
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